John Devlin is a Professor of Pharmacy at Northeastern University and an Associate Scientist in the Division of Pulmonary and Critical Care Medicine at Brigham and Women's Hospital, Boston, MA. His federally funded research program, focused on the detection, prevention and treatment of delirium and disrupted sleep in the ICU, as well as the epidemiology of medication-associated delirium and polypharmacy during and after critical illness, has generated nearly three million in funding and more than 200 publications. He is a member of the editorial boards of Critical Care Medicine and Pharmacotherapy, a past president of the American Delirium Society, and chaired the SCCM 2018 pain, agitation, delirium, immobility and disrupted sleep international clinical practice guidelines.